GlassScriptPhysician profile
Jonanne Jameson
NPI 1902380512
$2,770.62
in general payments reported to CMS, 2019-2025
26 companies · $518 in 2025
The $518 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $76.27 · 2022: $781 · 2023: $682 · 2024: $714 · 2025: $518.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,913.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $484.82 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Cvrx, INC. | $442.21 | 2022-2024 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $382.41 | 2023-2025 | Bridion |
| W. L. Gore & Associates, INC. | $233.34 | 2022-2023 | Gore Viabahn Vbx Balloon Expandable Endo, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Ets Wound Care LLC | $134.28 | 2024 | Mirragen Advanced Wound Matrix |
| Janssen Pharmaceuticals, INC | $131.37 | 2021-2024 | Xarelto |
| Novo Nordisk INC | $124.01 | 2022 | |
| Baxter Healthcare | $122.23 | 2022-2023 | Tisseel |
| Medtronic, INC. | $97.17 | 2021-2025 | In.Pact Av, Abre, Concertotm |
| Lemaitre Vascular, INC. | $63.82 | 2023-2025 | Artegraft Vascular Graft, Restoreflow |
| Surmodics, INC. | $61.63 | 2025 | Pounce Thrombectomy |
| Shockwave Medical, INC | $56.67 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Endologix LLC | $45.96 | 2021-2022 | |
| Boston Scientific Corporation | $44.56 | 2022-2023 | |
| Kerecis Limited | $42.79 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $38.07 | 2022-2023 | Pico 14 |
| Ethicon US, LLC | $37.36 | 2024 | Prolene, Evarrest, Vistaseal |
| Kci USA, INC. | $35.77 | 2021-2022 | |
| Organogenesis INC. | $35.52 | 2025 | Apligraf |
| Imperative Care, INC | $30.62 | 2024 | Prodigy Catheter |
| Cardiovascular Systems INC. | $25.77 | 2022 | |
| Solventum Corporation | $22.19 | 2024 | V.A.C. Veraflo Cleanse Choice, Prevena |
| Sanara Medtech INC. | $20.41 | 2025 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $19.45 | 2025 | |
| Bard Peripheral Vascular, INC. | $19.42 | 2025 | Venovo |
| Stryker Corporation | $18.77 | 2025 | Artix Mt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonanne Jameson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.